WeightWatchers announced that WeightWatchers for Business has fully integrated WW‘s science-proven behavioral program with its virtual obesity clinic and medication management. The Company now offers a full spectrum weight health platform designed for employers and health plans, that delivers individualized member pathways based on true clinical need. As prevalence of chronic diseases increases, organizations are challenged with higher costs, with experts predicting a 2-10% increase in insurance premiums in 2024. Among the many contributing factors are the increased utilization and cost of GLP-1 medications indicated for weight loss and diabetes. To help organizations navigate this new landscape, WeightWatchers for Business is building on its 30+ years of science-backed expertise in the employer-sponsored healthcare space with a complete cost management and utilization strategy that includes preventing progression and facilitating remission of weight-related conditions, as well as managing weight before, during, and after pharmacotherapy. WeightWatchers for Business utilizes evidence-based clinical pathways and step therapy with proprietary de-escalation protocols designed to drive clinically significant outcomes while controlling cost.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on WW:
- WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health
- Unusually active option classes on open October 5th
- WW upgraded, Macy’s downgraded: Wall Street’s top analyst calls
- Craig-Hallum upgrades WW to Hold amid enthusiasm for GLP-1 medications
- Davidson says Oprah panel legitimized drug treatment for obesity